Similar articles

• Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure.

  Lindenfeld J, Feldman AM, Saxon L, Boehmer J, Carson P, Ghali JK, Anand I, Singh S, Steinberg JS, Jaski B, DeMarco T, Mann D, Yong P, Galle E, Ecklund F, Bristow M. Lindenfeld J, et al. Circulation. 2007 Jan 16;115(2):204-12. doi: 10.1161/CIRCULATIONAHA.106.629261. Epub 2006 Dec 26. Circulation. 2007. PMID: 17190867 Clinical Trial.
• Cardiac resynchronization therapy in New York Heart Association class IV heart failure: it is all about selection.

  Tang WH, Francis GS. Tang WH, et al. Circulation. 2007 Jan 16;115(2):161-2. doi: 10.1161/CIRCULATIONAHA.106.669879. Circulation. 2007. PMID: 17228011 No abstract available.
• Survival in New York Heart Association class IV heart failure patients treated with cardiac resynchronization therapy compared with patients on optimal pharmacological treatment.

  Castel MA, Magnani S, Mont L, Roig E, Tamborero D, Méndez-Zurita F, Femenia JF, Tolosana JM, Pérez-Villa F, Brugada J. Castel MA, et al. Europace. 2010 Aug;12(8):1136-40. doi: 10.1093/europace/euq163. Epub 2010 Jun 12. Europace. 2010. PMID: 20543199
• Cardiac resynchronization therapy in heart failure patients: an update.

  Jeevanantham V, Daubert JP, Zareba W. Jeevanantham V, et al. Cardiol J. 2009;16(3):197-209. Cardiol J. 2009. PMID: 19437393 Review.
• Expanding cardiac resynchronization for systolic heart failure to patients with mechanical dyssynchrony and atrial fibrillation.

  Ghanbari H, Hassunizadeh B, Machado C. Ghanbari H, et al. Rev Cardiovasc Med. 2005 Summer;6(3):140-51. Rev Cardiovasc Med. 2005. PMID: 16195687 Review.